US Bancorp DE lifted its holdings in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 4.4% in the third quarter, HoldingsChannel reports. The institutional investor owned 34,017 shares of the financial services provider’s stock after acquiring an additional 1,422 shares during the period. US Bancorp DE’s holdings in iShares Nasdaq Biotechnology ETF were worth $4,148,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of IBB. Ruggie Capital Group grew its position in shares of iShares Nasdaq Biotechnology ETF by 1.2% in the 2nd quarter. Ruggie Capital Group now owns 37,489 shares of the financial services provider’s stock valued at $4,117,000 after buying an additional 441 shares during the last quarter. Northstar Group Inc. boosted its position in shares of iShares Nasdaq Biotechnology ETF by 5.5% during the 2nd quarter. Northstar Group Inc. now owns 8,680 shares of the financial services provider’s stock valued at $920,000 after purchasing an additional 450 shares in the last quarter. Bartlett & Co. LLC boosted its position in shares of iShares Nasdaq Biotechnology ETF by 4.5% during the 3rd quarter. Bartlett & Co. LLC now owns 10,736 shares of the financial services provider’s stock valued at $1,309,000 after purchasing an additional 462 shares in the last quarter. CIBC Private Wealth Group LLC boosted its position in shares of iShares Nasdaq Biotechnology ETF by 0.8% during the 2nd quarter. CIBC Private Wealth Group LLC now owns 60,936 shares of the financial services provider’s stock valued at $6,692,000 after purchasing an additional 467 shares in the last quarter. Finally, Janney Montgomery Scott LLC boosted its position in shares of iShares Nasdaq Biotechnology ETF by 0.6% during the 2nd quarter. Janney Montgomery Scott LLC now owns 76,623 shares of the financial services provider’s stock valued at $8,415,000 after purchasing an additional 469 shares in the last quarter. 65.90% of the stock is owned by institutional investors.

Shares of iShares Nasdaq Biotechnology ETF stock opened at $104.45 on Tuesday. iShares Nasdaq Biotechnology ETF has a one year low of $100.22 and a one year high of $122.97.

WARNING: “iShares Nasdaq Biotechnology ETF (IBB) Shares Bought by US Bancorp DE” was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at https://www.dailypolitical.com/2018/11/13/ishares-nasdaq-biotechnology-etf-ibb-shares-bought-by-us-bancorp-de.html.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Article: Compound Interest and Why It Matters When Investing

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.